Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Entrepreneurship Guest Lecture Series

Publication date: Feb 06, 2013 08:00 AM

Start: Feb 28, 2013 05:15 PM

Reece Howe - Director and founder of Kirkwood Care
Each year, UCL's Department of Management Science and Innovation and UCL Advances organises a series of guest lectures from leading entrepreneurs and investors.

Kirkwood care

Reece founded Kirkwood Care in 2009 to provide an alternative: personal, respectful and dignified support for elderly, ill and disabled people where it is needed most: in their own homes. Since establishment, Kirkwood Care has grown rapidly due to its excellent reputation among customers and healthcare professionals.

Find out more about the Entrepreneurship Guest Lectures